Profound Medical
PROF
45 hedge funds and large institutions have $124M invested in Profound Medical in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
57% more capital invested
Capital invested by funds: $79.2M → $124M (+$45.1M)
32% more funds holding
Funds holding: 34 → 45 (+11)
29% more call options, than puts
Call options by funds: $1.42M | Put options by funds: $1.1M
7.36% more ownership
Funds ownership: 28.98% → 36.34% (+7.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$11M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.15M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$6.75M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$3.65M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$4.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.34M |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
-$1.1M |
| 4 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$221K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$178K |
PROF Hedge Fund Activity: Q3 2020 in Review
45 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2020, worth a combined $124M — up 57% from $79.2M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PROF positions and 5 closed out — a net gain of 11 holders — while 20 added to existing stakes and 5 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $11M. The largest seller was Royce & Associates, cutting an estimated $4.5M.
- 45 institutional investors held Profound Medical (PROF) as of Q3 2020, up from 34 in Q2 2020.
- Funds reported $124M of Profound Medical stock for Q3 2020, up 57% quarter-over-quarter.
- 16 funds opened new Profound Medical positions in Q3 2020 and 5 closed out, a net change of +11 holders.
- The largest Profound Medical buyer in Q3 2020 was Deerfield Management, an estimated $11M added.
- The largest Profound Medical seller in Q3 2020 was Royce & Associates, an estimated $4.5M sold.
Based on aggregated 13F filings for Q3 2020.